AAAAAA
Results:
1-22
|
Results: 22
Authors:
Lafeuillade, A
Halfon, P
Chadapaud, S
Hittinger, G
Khiri, H
Poggi, C
Citation: A. Lafeuillade et al., Potential adverse effects of structured therapeutic interruptions on the pool of HIV-infected cells, J ACQ IMM D, 28(2), 2001, pp. 197-199
Authors:
Halfon, P
Eggli, Y
Citation: P. Halfon et Y. Eggli, Screening inappropriate hospital days on the basis of routinely available data, INT J QUAL, 13(4), 2001, pp. 289-299
Authors:
Lafeuillade, A
Khiri, H
Chadapaud, S
Hittinger, G
Halfon, P
Citation: A. Lafeuillade et al., Persistence of HIV-1 resistance in lymph node mononuclear cell RNA despiteeffective HAART, AIDS, 15(15), 2001, pp. 1965-1969
Authors:
Halfon, P
Trimoulet, P
Bourliere, M
Khiri, H
de Ledinghen, V
Couzigou, P
Feryn, JM
Alcaraz, P
Renou, C
Fleury, HJA
Ouzan, D
Citation: P. Halfon et al., Hepatitis C virus genotyping based on 5 ' noncoding sequence analysis (Trugene), J CLIN MICR, 39(5), 2001, pp. 1771-1773
Authors:
Halfon, P
Riflet, H
Renou, C
Quentin, Y
Cacoub, P
Citation: P. Halfon et al., Molecular evidence of male-to-female sexual transmission of hepatitis C virus after vaginal and anal intercourse, J CLIN MICR, 39(3), 2001, pp. 1204-1206
Authors:
Renou, C
Muller, P
Louve, E
Bertrand, JJ
Raoult, A
Benderriter, T
Halfon, P
Citation: C. Renou et al., Relevance of moderate isolated thrombopenia as a strong predictive marker of cirrhosis in patients with chronic hepatitis C virus, AM J GASTRO, 96(5), 2001, pp. 1657-1659
Authors:
Clevenbergh, P
Durant, J
Halfon, P
del Giudice, P
Mondain, V
Montagne, N
Schapiro, JM
Boucher, CAB
Dellamonica, P
Citation: P. Clevenbergh et al., Persisting long-term benefit of genotype-guided treatment for HIV-infectedpatients failing HAART. The Viradapt study: week 48 follow-up, ANTIVIR TH, 5(1), 2000, pp. 65-70
Authors:
Durant, J
Clevenbergh, P
Garraffo, R
Halfon, P
Icard, S
Del Giudice, P
Montagne, N
Schapiro, JM
Dellamonica, P
Citation: J. Durant et al., Importance of protease inhibitor plasma levels in HIV-infected patients treated with genotypic-guided therapy: pharmacological data from the ViradaptStudy, AIDS, 14(10), 2000, pp. 1333-1339
Authors:
Halfon, P
Cacoub, P
Citation: P. Halfon et P. Cacoub, Quantitation of hepatitis C virus RNA: present and future., REV MED IN, 21(2), 2000, pp. 174-181
Authors:
Lefrere, JJ
Lerable, J
Mariotti, M
Bogard, M
Thibault, V
Frangeul, L
Loiseau, P
Bouchardeau, F
Laperche, S
Pawlotsky, JM
Cantaloube, JF
Biagini, P
de Lamballerie, X
Izopet, J
Defer, C
Lepot, I
Poveda, JD
Dussaix, E
Gerolami, V
Halfon, P
Buffet-Janvresse, C
Ferec, C
Mercier, B
Marcellin, P
Martinot-Peignoux, M
Gassain, M
Merel, P
Lamoril, J
Coste, J
Roudet-Thoraval, F
Citation: Jj. Lefrere et al., Lessons from a multicentre study of the detectability of viral genomes based on a two-round quality control of GB virus C (GBV-C)/hepatitis G virus (HGV) polymerase chain reaction assay, J VIROL MET, 85(1-2), 2000, pp. 117-124
Authors:
Halfon, P
Halimi, G
Bourliere, M
Ouzan, D
Durant, J
Khiri, H
Mercier, L
Gerolami, V
Cartouzou, G
Citation: P. Halfon et al., Integrity of the NS5A (amino acid 2209 to 2248) region in hepatitis C virus 1b patients non-responsive to interferon therapy, LIVER, 20(5), 2000, pp. 381-386
Authors:
Debono, E
Halfon, P
Bourliere, M
Gerolami-Santandrea, V
Gastaldi, M
Castellani, P
Cartouzou, G
Botta-Fridlund, D
Cau, P
Gauthier, A
Citation: E. Debono et al., Absence of hepatitis C genome in semen of infected men by polymerase chainreaction, branched DNA and in situ hybridization, LIVER, 20(3), 2000, pp. 257-261
Authors:
Bourliere, M
Halfon, P
Quentin, Y
David, P
Mengotti, C
Portal, I
Khiri, H
Benali, S
Perrier, H
Boustiere, C
Jullien, M
Lambot, G
Citation: M. Bourliere et al., Covert transmission of hepatitis C virus during bloody fisticuffs, GASTROENTY, 119(2), 2000, pp. 507-511
Authors:
Martinot-Peignoux, M
Roudot-Thoraval, F
Mendel, I
Coste, J
Izopet, J
Duverlie, G
Payan, C
Pawlotsky, JM
Defer, C
Bogard, M
Gerolami, V
Halfon, P
Buisson, Y
Fouqueray, B
Loiseau, P
Lamoril, J
Lefrere, JJ
Marcellin, P
Citation: M. Martinot-peignoux et al., Hepatitis C virus genotypes in France: relationship with epidemiology, pathogenicity and response to interferon therapy, J VIRAL HEP, 6(6), 1999, pp. 435-443
Authors:
Halfon, P
Cacoub, P
Citation: P. Halfon et P. Cacoub, Transmitted Transfusion Virus (TTV): a new hepatotropic virus ... looking for a disease, PRESSE MED, 28(29), 1999, pp. 1592-1594
Authors:
Halfon, P
Quentin, Y
Roquelaure, B
Sarles, J
Halimi, G
Gerolami, V
Khiri, H
Bourliere, M
Cartouzou, G
Citation: P. Halfon et al., Mother-to-infant transmission of hepatitis C virus: molecular evidence of superinfection by homologous virus in children, J HEPATOL, 30(6), 1999, pp. 970-978
Authors:
Durant, J
Clevenbergh, P
Halfon, P
Delgiudice, P
Porsin, S
Simonet, P
Montagne, N
Boucher, CAB
Schapiro, JM
Dellamonica, P
Citation: J. Durant et al., Drug-resistance genotyping in HIV-1 therapy: the VIRADAPT randomised controlled trial, LANCET, 353(9171), 1999, pp. 2195-2199
Authors:
Mercier, B
Barclais, A
Botte, C
Cantalube, JF
Coste, J
Defer, C
Gautreau, C
Giannoli, C
Halfon, P
Lepot, I
Loiseau, P
Martial, J
Montcharmont, P
Merel, P
Ouzan, D
Ravera, N
Follana, J
Cesaire, R
Janot, C
Lemaire, JM
De Micco, P
Vezon, G
Ferec, C
Citation: B. Mercier et al., Prevalence of GBV C HGV RNA and GBV C HGV antibodies in French volunteer blood donors: Results of a collaborative study, VOX SANGUIN, 76(3), 1999, pp. 166-169
Authors:
Periard, D
Telenti, A
Sudre, P
Cheseaux, JJ
Halfon, P
Reymond, MJ
Marcovina, SM
Glauser, MP
Nicod, P
Darioli, R
Mooser, V
Citation: D. Periard et al., Atherogenic dyslipidemia in HIV-infected individuals treated with proteaseinhibitors, CIRCULATION, 100(7), 1999, pp. 700-705
Authors:
Cacoub, P
Halfon, P
Musset, L
Citation: P. Cacoub et al., Transfusion-transmitted virus and mixed cryoglobulinemia, ANN INT MED, 130(5), 1999, pp. 451-452
Authors:
Lunel, F
Poinsot, H
Bogard, M
Brechot, C
Defer, C
Duverlie, G
Fouqueray, B
Halfon, P
Lewine, P
Loiseau, P
Marcellin, P
Zarski, JP
Stuyver, L
Citation: F. Lunel et al., Prevalence and characteristics of genotype 2 subtypes in France, HEPATITIS C VIRUS: GENETIC HETEROGENEITY AND VIRAL LOAD, 1997, pp. 111-114
Authors:
Halfon, P
Khiri, H
Gerolami, V
Alimi, JP
Halimi, G
Feryn, JM
Legros, S
Bourliere, M
Sarles, J
Cartouzou, G
Citation: P. Halfon et al., Molecular evidence of mother-to-infant transmission of hepatitis C by quasispecies analysis, HEPATITIS C VIRUS: GENETIC HETEROGENEITY AND VIRAL LOAD, 1997, pp. 115-118
Risultati:
1-22
|